Q1 2026 earnings call highlights: 58% revenue growth, 77% margins, raised FY26 outlook and CMS reimbursement updates—read the key takeaways.

DoorDash faces multiple compression amid slowing core growth and the sizable Deliveroo acquisition. Read why DASH stock is a ...

Carlsmed, Inc. ( CARL) Q1 2026 Earnings Call May 5, 2026 4:30 PM EDT Ladies and gentlemen, thank you for standing by, and welcome to the Carlsmed First Quarter 2026 Earnings Conference Call. [Operator ...

Protean Small Cap gained 7.5% in April, outperforming its index as inception returns reached 67.6%. Read the full analysis ...

Protean Funds shifts from a short to a long position in Vend as AI fears subside and valuation improves. Read the full ...

Analysts expect sales to remain steady across much of the industry, while rising cost pressures and uneven demand ...

Protean Funds explores Yubico's valuation and the impact of AI on the cybersecurity hardware market. Read the full analysis ...

Nova Minerals secured $43.4M in non-dilutive Defense Production Act funding, strengthening liquidity to A$89.4M. Read why NVA ...

Full-year 2026 total revenue guidance shifted to "approximately $882 million" (Executive VP & CFO Koning) from "approximately $890 million" (Executive VP & CFO Koning) previously, while surgical ...

Good afternoon and thank you for joining Emerson's Second Quarter 2026 Earnings Conference Call. Today, I'm joined by Emerson's President and Chief Executive Officer, Lal Karsanbhai; Chief Financial ...

Total revenues were $19.4 million for Q1 2026, including $4.8 million in net product revenue for MYQORZO, $2.6 million in collaboration revenue, and $11.9 million from a Bayer license milestone tied ...

Q1 2026. Management View "I am pleased to report that Rapid7 delivered outperformance against all guided metrics" (CEO Corey Thomas), includin ...